多参数MRI上肿瘤多灶性与PI-RADS 4分病灶中临床显著性前列腺癌检出之间的关联
研究纳入至少有一个PI-RADS 4分病灶并接受多参数MRI-超声融合前列腺活检的患者,按病灶多灶性及合并病灶PI-RADS评分分为4组,比较靶向活检PI-RADS 4分病灶中GG≥2病理检出率。总体GG≥2检出率为35.2%,各组分别为21.7%、36.3%、49.1%和42.7%(P<.001),年龄、临床分期T2、PSA密度、外周带病灶及研究分组与GG≥2风险显著相关。
要点
- PI-RADS 4分病灶靶向活检GG≥2总体检出率为35.2%。
- 合并其他PI-RADS 4分病灶组GG≥2检出率49.1%,高于单发PI-RADS 4分组36.3%。
- 年龄、临床分期T2、PSA密度、外周带病灶及分组与GG≥2风险独立相关。
核心结论
- PI-RADS 4分病灶靶向活检中GG≥2病理比例约为35%,其检出率可能因病灶位置、多灶性及其他病灶PI-RADS分类而异。
研究设计与样本
- 研究纳入至少有一个PI-RADS 4分病灶并接受多参数MRI-超声融合前列腺活检的患者,按病灶情况分为4组:第1组为PI-RADS 4分指数病灶加一个PI-RADS 2或3分病灶,第2组为单发PI-RADS 4分病灶,第3组为2个及以上PI-RADS 4分病灶,第4组为PI-RADS 4分病灶加一个PI-RADS 5分指数病灶。
主要发现
- PI-RADS 4分病灶靶向活检GG≥2总体检出率为35.2%。
- 第1、2、3、4组PI-RADS 4分病灶GG≥2检出率分别为21.7%、36.3%、49.1%、42.7%(P<.001)。
- 多因素分析显示,年龄(OR 1.06,P<.001)、临床分期T2(OR 1.59,P=.03)、前列腺特异性抗原密度(OR 1.43,P<.001)、外周带病灶(OR 1.62,P=.04)及研究分组(第2组 vs 第1组,OR 1.93,P=.006;第3组 vs 第1组,OR 3.28,P<.001)与PI-RADS 4分病灶GG≥2风险显著相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate whether presence of multifocality on multi-parametric magnetic resonance imaging would increase the likelihood of detecting clinically-significant prostate cancer in a PI-RADS 4 lesion. METHODS: We identified patients with at least 1 PI-RADS 4 lesion who underwent multi-parametric magnetic resonance imaging-ultrasound fusion prostate biopsy. Patients were grouped into 1 of 4 cohorts-cohort 1 (a PI-RADS 4 index lesion and an additional PI-RADS 2 or 3 lesion), cohort 2 (single lesion with PI-RADS 4), cohort 3 (2 or more PI-RADS 4 lesions), or cohort 4 (a PI-RADS 4 lesion and an index lesion with PI-RADS 5). We compared the rate of grade group (GG) ≥ 2 pathology on targeted biopsy of PI-RADS 4 lesions between cohorts and evaluated clinical and radiological factors associated with cancer detection. RESULTS: The overall rate of GG ≥ 2 pathology in the PI-RADS 4 lesions was 35.2%. The rate of GG ≥ 2 pathology in the cohorts 1, 2, 3, and 4 was 21.7%, 36.3%, 49.1%, and 42.7%, respectively (P< .001). On multivariable analysis, age (OR1.06, P < .001), clinical stage T2 (OR1.59, P= .03), prostate-specific antigen density (OR1.43, P < .001), peripheral zone lesion (OR1.62, P = .04), and study cohort (cohort 2 vs 1, OR1.93, P = .006; and cohort 3 vs 1, OR3.28, P < .001) were significantly associated with the risk of GG ≥ 2 in the PI-RADS 4 lesion. CONCLUSION: On targeted biopsy of the PI-RADS 4 lesions, the proportion of GG ≥ 2 pathology is approximately 35%. Rate of GG ≥ 2 detection in PI-RADS 4 lesions might differ based on their location, multifocality, and PI-RADS classifications of other lesions identified.
引用
- Ghabili K, Swallow M, Sherrer RL, et al. Association Between Tumor Multifocality on Multi-parametric MRI and Detection of Clinically-Significant Prostate Cancer in Lesions with Prostate Imaging Reporting and Data System (PI-RADS) Score 4. Urology. 2019. PMID: 31419433. doi:10.1016/j.urology.2019.08.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。